Adenoviral VEGF-DΔN ΔC gene therapy for myocardial ischemia
Background: Cardiovascular diseases are the leading cause of death globally. In spite of the availability of improved treatments, there is still a large group of chronic ischemia patients who suffer from significant symptoms and disability. Thus, there is a clear need to develop new treatment strate...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2022-12-01
|
| Serie: | Frontiers in Bioengineering and Biotechnology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.999226/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|